These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35454343)

  • 1. Ramadan Intermittent Fasting Is Associated with Changes in Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Metabolically Healthy Obese Subjects.
    Hasan H; Madkour M; Awadallah S; Hassanein M; Jahrami H; Faris M
    Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population.
    Hamamura H; Adachi H; Enomoto M; Fukami A; Nakamura S; Nohara Y; Morikawa N; Sakaue A; Toyomasu K; Yamamoto M; Fukumoto Y
    J Atheroscler Thromb; 2021 Apr; 28(4):329-337. PubMed ID: 32624555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.
    Simonen P; Stenman UH; Gylling H
    Clin Sci (Lond); 2015 Sep; 129(5):439-46. PubMed ID: 25857271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication.
    Furuhashi M; Omori A; Matsumoto M; Kataoka Y; Tanaka M; Moniwa N; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
    Am J Cardiol; 2016 Jul; 118(2):198-203. PubMed ID: 27241838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI.
    Wild RA; Weedin E; Cox K; Zhao YD; Wrenn DS; Lopez D; Wooten CJ; Melendez QM; Myers D; Hansen KR
    J Clin Lipidol; 2022; 16(4):483-490. PubMed ID: 35717446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study.
    Noguchi T; Kobayashi J; Yagi K; Nohara A; Yamaaki N; Sugihara M; Ito N; Oka R; Kawashiri MA; Tada H; Takata M; Inazu A; Yamagishi M; Mabuchi H
    Atherosclerosis; 2011 Jul; 217(1):165-70. PubMed ID: 21411093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study.
    Shi J; Zhang W; Niu Y; Lin N; Li X; Zhang H; Hu R; Ning G; Fan J; Qin L; Su Q; Yang Z
    Cardiovasc Diabetol; 2020 Dec; 19(1):209. PubMed ID: 33302966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
    Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiretroviral therapy on proprotein convertase subtilisin/kexin 9: focus on lipids, inflammation and immunovirological parameters.
    Bianconi V; Schiaroli E; Pirro M; Cardaci S; Busti C; Mannarino MR; Baldelli F; Francisci D
    HIV Med; 2020 Sep; 21(8):512-522. PubMed ID: 32496664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Ramadan diurnal fasting on visceral adiposity and serum adipokines in overweight and obese individuals.
    Faris MAE; Madkour MI; Obaideen AK; Dalah EZ; Hasan HA; Radwan H; Jahrami HA; Hamdy O; Mohammad MG
    Diabetes Res Clin Pract; 2019 Jul; 153():166-175. PubMed ID: 31150725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics.
    Gauthier MS; Awan Z; Bouchard A; Champagne J; Tessier S; Faubert D; Chabot K; Garneau PY; Rabasa-Lhoret R; Seidah NG; Ridker PM; Genest J; Coulombe B
    J Clin Lipidol; 2018; 12(4):1027-1038. PubMed ID: 29699916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proprotein Convertase Subtilisin/Kexin type 9 affects insulin but not lipid metabolism in cystic fibrosis.
    Coriati A; Arslanian E; Bouvet GF; Prat A; Seidah NG; Rabasa-Lhoret R; Berthiaume Y
    Clin Invest Med; 2017 Apr; 40(2):E59-E65. PubMed ID: 28447578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum PCSK9, a potential biomarker to screen for periodontitis, and decreased total bilirubin associated with probing depth in a Japanese community survey.
    Tabeta K; Hosojima M; Nakajima M; Miyauchi S; Miyazawa H; Takahashi N; Matsuda Y; Sugita N; Komatsu Y; Sato K; Ishikawa T; Akiishi K; Yamazaki K; Kato K; Saito A; Yoshie H
    J Periodontal Res; 2018 Jun; 53(3):446-456. PubMed ID: 29516504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiposity blunts the positive relationship of thyrotropin with proprotein convertase subtilisin-kexin type 9 levels in euthyroid subjects.
    Kwakernaak AJ; Lambert G; Muller Kobold AC; Dullaart RP
    Thyroid; 2013 Feb; 23(2):166-72. PubMed ID: 23106476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calorically restricted diets decrease PCSK9 in overweight adolescents.
    Levenson AE; Milliren CE; Biddinger SB; Ebbeling CB; Feldman HA; Ludwig DS; de Ferranti SD
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):342-349. PubMed ID: 28228332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent fasting during Ramadan causes a transient increase in total, LDL, and HDL cholesterols and hs-CRP in ethnic obese adolescents.
    Radhakishun N; Blokhuis C; van Vliet M; von Rosenstiel I; Weijer O; Heymans M; Beijnen J; Brandjes D; Diamant M
    Eur J Pediatr; 2014 Aug; 173(8):1103-6. PubMed ID: 24522324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals.
    Macchi C; Ferri N; Favero C; Cantone L; Vigna L; Pesatori AC; Lupo MG; Sirtori CR; Corsini A; Bollati V; Ruscica M
    Eur J Prev Cardiol; 2019 Apr; 26(6):578-588. PubMed ID: 30477320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women.
    Levenson AE; Shah AS; Khoury PR; Kimball TR; Urbina EM; de Ferranti SD; Maahs DM; Dolan LM; Wadwa RP; Biddinger SB
    Pediatr Diabetes; 2017 Dec; 18(8):755-760. PubMed ID: 28093849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".
    Kohli P; Ganz P; Ma Y; Scherzer R; Hur S; Weigel B; Grunfeld C; Deeks S; Wasserman S; Scott R; Hsue PY
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood Levels of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Men from Different Population Groups and Its Relation to Unfavorable Long-Term Prognosis].
    Ragino YI; Astrakova KS; Shakhtshneider EV; Stakhneva EM; Gafarov VV; Bogatyrev SN; Voevoda MI
    Kardiologiia; 2017 Apr; 57(4):72-76. PubMed ID: 28762908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.